The following questions provide general scientific and product information for Semax and the analytical documentation associated with Whitey’s Peps research materials.
Semax is a synthetic heptapeptide consisting of the ACTH(4–7) sequence with a C-terminal Pro-Gly-Pro (PGP) extension. Research has investigated Semax in relation to neurobiology, cognitive processes, and neuroprotective activity.
Research has examined Semax in relation to learning and memory, attention, neurotrophic signaling, neuronal responses, and experimental models of neurological injury.
Experimental research has found that Semax can alter BDNF expression and protein levels in brain regions involved in learning and memory. Studies in rats have also examined changes involving the BDNF receptor TrkB.
Yes. Research has investigated Semax in relation to learning, memory, and attention. Studies have included animal models as well as human research, although the evidence and study conditions vary considerably.
Yes. Experimental research has investigated Semax in models of cerebral ischemia and other neurological injury. Studies have examined neurotrophic signaling, inflammatory responses, and changes in gene expression following ischemic injury, particularly in animal models.
Where applicable, independent laboratory documentation may provide information about product identity, purity, and other analytical characteristics of a tested batch. Analytical results apply only to the specific sample or batch identified in the applicable laboratory documentation.